Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Genomic signatures in plasma circulating tumor DNA reveal treatment response and prognostic insights in mantel cell lymphoma

Fig. 1

Overview of study design. Baseline tissue biopsies and plasma ctDNA from 34 MCL patients receiving first-line chemotherapy were analyzed using targeted next-generation sequencing to characterize the mutational landscape and assess the concordance of somatic genomic variant detection between paired samples. Pretreatment ctDNA was further investigated to evaluate its association with treatment response and prognosis. Longitudinal plasma samples from representative patients highlighted the importance of interim ctDNA monitoring for disease surveillance

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us